alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
**Exhibit 24**

**LIMITED POWER OF ATTORNEY**

KNOW ALL MEN BY THESE PRESENTS, that the undersigned director and/orofficer of Family Dollar Stores, Inc., a Delaware corporation (the “Company”), does hereby make, constitute and appoint Howard R. Levine, R. James Kelly, Kenneth T. Smith, Janet G. Kelley and each or any one of them, the undersigned’strue and lawful attorneys-in-fact, with power of substitution, for the undersigned and in the undersigned’s name, place and stead, to sign and affix the undersigned’s name as director and/or officer of the Company to the Company’sAnnual Report on Form 10-K for the fiscal year ended August 30, 2008, pursuant to the Securities Exchange Act of 1934, as amended (the “1934 Act”), including any and all exhibits, schedules, supplements, certifications and supportingdocuments thereto, and all amendments, supplementations, and corrections thereto, to be filed by the Company with the Securities and Exchange Commission (the “SEC”). 

The undersigned also grants to said attorneys-in-fact, and each of them, full power and authority to do and perform any and all acts necessary orincidental to the performance and execution of the powers herein expressly granted. This Power of Attorney shall remain in effect until revoked in writing by the undersigned. 

IN WITNESS WHEREOF, the undersigned has signed below effective as of this             day of October, 2008.
Resolution No. 10/16-2 

ADVISORY COMMITTEE ON IMMUNIZATION PRACTICES

VACCINES FOR CHILDREN PROGRAM

VACCINES TO PREVENT HUMAN PAPILLOMAVIRUS

The purpose of this resolution is to reflect the new dosing schedules for human 

papillomavirus vaccine.

VFC Resolution 02/15-2 is repealed and replaced by the following:

Eligible Groups 

All children aged 9 through 18 years. 

Recommended schedule and intervals

ACIP recommends routine HPV vaccination at age 11 or 12 years, and vaccination can

be given starting at age 9 years. ACIP also recommends vaccination for females and 

males age 13 through 18 years who were not adequately vaccinated previously. 

The table below summarizes the recommended number of recommended HPV vaccine 

doses and schedule for specific groups of children. 

Recommended 

number of doses

Recommended 

dosing schedule

Population

2 0, 6–12 months1 Persons initiating vaccination at age 9 through 14 

years, except immunocompromised persons2

3 0, 1–2, 6 months3 Persons initiating vaccination at age 15 through 18

years, and immunocompromised persons2 initiating 

vaccination at 9 through 18 years 

Table Notes:

1. In a 2-dose schedule of HPV vaccine, the minimum interval is 5 months between

the first and the second dose.

2. Persons with primary or secondary immunocompromising conditions that might reduce

cell-mediated or humoral immunity.

3. In a 3-dose schedule of HPV vaccine, the minimum intervals are 1 month between the

first and second dose, 3 months between the second and third dose, and 5 months

between the first and third dose.

1 
Persons who initiated vaccination with 9vHPV, 4vHPV, or 2vHPV before the 15th 

birthday, and received 2 doses at the recommended dosing schedule, or 3 doses at the 

recommended dosing schedule, are considered adequately vaccinated.

Persons who initiated vaccination with 9vHPV, 4vHPV, or 2vHPV on or after the 15th 

birthday, and received 3 doses at the recommended dosing schedule, are considered

adequately vaccinated.

Vaccine doses administered at shorter than minimum intervals should be re-administered

as recommended. 

9vHPV may be used to continue or complete a series started with another HPV vaccine.

If the vaccine schedule is interrupted, the series does not need to be restarted. 

Recommended dosage

Refer to product package inserts. 

Precautions and contraindications 

Precautions and contraindications can be found in the package inserts available at: 

http://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM093833. 

[If an ACIP recommendation regarding the human papillomavirus vaccination is

published within 12 months following this resolution, the relevant language above 

(except in the eligible groups sections) will be replaced with the language in the

recommendation and incorporated by reference to the publication URL.] 

Adopted and Effective: October 19, 2016 

This document can be found on the CDC website at: 

https://www.cdc.gov/vaccines/programs/vfc/providers/resolutions.html

2
ID Descriptor L* a* b* c h dL* da* db* dEcmc*

Standard 3846 STANDARD 37.66 -1.94 3.30

Tolerance

1 3846A BLUE LIMIT 40.47 -2.32 2.42 2.81 -0.38 -0.88 1.91

2 3846B BLUE-GREEN 

LIMIT 37.12 -2.07 2.8 -0.54 -0.13 -0.5 0.69

3 3846C THIN GREEN 

LIMIT 38.56 -2.07 3.00 0.90 -0.13 -0.3 0.62

4

5

6

7

8

9

COMMENTS: NUMBERS ARE FOR REFERENCE ONLY 

Equipment Type HUNTER ULTRA SCAN PRO Setting Mode: Specular Included - 

Reflectance

UV Filter – OUT UV Lamp OFF

DLA/ARMY SHADE TOLERANCE PROJECT September 6, 2018

Fabric Nomenclature HOOD, BALACLAVA, EXTENDED COLD 

WEATHER A-A-50194B

Shade Number FOLIAGE GREEN 504 Piece/Roll Number 3846
(1) Adjusting Price $18.78 CWT

(2) Base Price $19.23 CWT

(3) Change from Base Price per CWT ($0.45)

(4) Price change per gallon ($0.0387)

(Line (3) divide by 11.63 gallons/cwt)

(5) Price change per half gallon ($0.0193)

Price change per quart ($0.0097)

Price change per pint ($0.0048)

Price change per 12-oz pg. ($0.0036)

Price change per 1/3 qt. (10-oz) ($0.0030)

Price change per half pint ($0.0024)

(6) Price adjustment per gallon ($0.04)

Price adjustment per half gallon ($0.02)

Price adjustment per quart ($0.01)

Price adjustment per pint ($0.00)

Price change per 12-oz pg. ($0.00)

Price adjustment per 1/3 qt. (10-oz) ($0.00)

Price adjustment per half pint ($0.00)

NOTE: Numbers in brackets are negative or decreases, all others are positive or increases.

Monthly EPA Calculation for Class I Milk (Clause 52.216-9032 Alt. I)

Based on California Dept. of Food and Agriculture Announcement of Minimum Prices

 Effective Date: Jan. 1, 2017
No. 11-6358.

#### Dickinson Norman Adionser, Petitioner v. United States.

565 U.S. 969, 132 S. Ct. 467,

181 L. Ed. 2d 305,

2011 U.S. LEXIS 7539.

October 17, 2011.

Petition for writ of certiorari to the United States Court of Appeals for the Fourth Circuit denied.

Same case below, 417 Fed. Appx. 305.
CS302401-A

The World of Workplace Health Programs

New Survey Shows Range of Health Promotion Programs in the U.S.

Percentage of U.S. worksites 

that offered specific health 

programs, 2017.

Note: Responses are from U.S. worksites with 10 or more employees. 

Source: CDC Workplace Health in America Survey, 2017

29%

Physical 

Activity

23%

Nutrition/Healthy 

Eating 10%

Healthy 

Sleep

12%

Musculoskeletal

Disorders,

Back Pain, 

Arthritis

20%

Stress

Management

17%

Obesity/Weight

Management

19%

Tobacco 

Cessation

14%

Excessive Alcohol 

and/or Drug Abuse

8%

Lactation

Support

www.cdc.gov/workplacehealthpromotion

Workplace Health

is moving in the 

right direction.

46% of U.S. 

worksites offer some 

type of health program 

to employees.
For more information: www.cdc.gov/COVID19

Considerations for Populations 

Included in Phase 1b and 1c

ACIP COVID-19 Vaccines

Sara Oliver MD, MSPH

ACIP Meeting

December 20, 2020
2

 Transitioning between phases

 Sub-prioritization considerations 

 Other considerations for Phase 1b and 1c 

Considerations for Phase 1b and 1c
Considerations: 

Transitioning between phases
Transitioning Between Phases

4

 Strategy for transitioning between phases will be necessary to move to the 

next phase as supply increases and exceeds demand for the current phase 

 Phases may overlap; not necessary to fully complete vaccination in one 

phase before moving to the next phase 

 Decisions on moving to the next phase made at a state/local level
Transitioning Between Phases

5

 Demand in current phase is less than vaccination capacity

–

–

For example, appointments for vaccine <80% filled for several days

 Supply increases significantly

More doses available of current vaccine or new vaccine authorized

 Most persons within current phase vaccinated (>60-70%)
Considerations: 

Sub-prioritization
Sub-prioritization Considerations

7

 Where sub-prioritization of frontline essential workers is needed due to 

limited vaccine supply, consider:

–

–

–

Workers in locations where high rates of transmission and/or outbreaks have 

occurred 

Workers who are at increased risk for severe illness based on age or underlying 

medical conditions*

Workers who do not have a history of documented acute SARS-CoV-2 infection 

in prior 90 days

*Self-identified medical conditions
Sub-prioritization Considerations

https://www.cdc.gov/mmwr/volumes/69/wr/pdfs/mm6947e3-H.pdf 8
Considerations: 

Other considerations for Phase 1b and 1c
Other Considerations

10

 mRNA vaccines are currently not recommended for outbreak management 

or for post-exposure prophylaxis (vaccination to prevent the development of 

SARS-CoV-2 infection in a person with an exposure) 

– Both mRNA vaccines are a 2-dose series; 1-2 weeks following the second dose 

before a person considered fully vaccinated

– Median incubation period for SARS-CoV-2 is 4-5 days

 Based on local epidemiology and implementation considerations, 

jurisdictions may choose to vaccinate frontline essential workers and 

persons who reside at congregate living facilities (e.g., prisons, jails, 

homeless shelters) at the same time
Other Considerations

11

 Communities that have been disproportionately affected by COVID-19 and 

have a younger population distribution, such as American Indian persons or 

Alaska Native persons, may choose to adopt an age cut-off appropriate to 

the epidemiologic circumstances in those communities
For more information, contact CDC

1-800-CDC-INFO (232-4636)

TTY: 1-888-232-6348 www.cdc.gov

The findings and conclusions in this report are those of the authors and do not necessarily represent the 

official position of the Centers for Disease Control and Prevention.

Thank you
November 30, 2022 DLA-SM-23-3225

DLA - Strategic Materials Announces

Zinc Offering 

 

 

FORT BELVOIR, Va. – The Defense Logistics Agency - Strategic 

Materials announced on November 30, 2022 that 700 ST of Zinc has been 

opened under DLA-Stockpile Materials-001-(Negotiated) Amendment No. 

001 (FY 2023 ZINC). 

Offers must be submitted online via the DLA-Strategic Materials Sales Portal 

at https://businessportal.dla.mil/irj/portal. 

Please note the pre-registration requirements prior to offering on this 

material.

Offers must be submitted by Friday December 9, 2022 by 10:00 am Local 

Time, Ft. Belvoir, VA.

For additional information please visit our website

https://www.dla.mil/Strategic-Materials/ or contact DLA Strategic Materials 

Directorate of Strategic Planning and Market Research at 

DLAStrategicMaterials@dla.mil.
January 10, 2020 

Dear DLA Strategic Materials Sales Customer: 

This letter provides important information in regards to submission of EFT payments. 

Below are instructions on how to submit your payment via EFT (Automated Clearing House ACH 

Credit, and Fedwire domestic and international). 

§r 6355 ·ALc: ACH info:/ 

Bank Name: Credit Gateway 

Address: 401 14th St. Washington, D.C. 20227 

Telephone: 1-877-815-1206 

Receiving DFI ID (ABA Routing#): 051036706 

DFI Account#: 800006355005 

Standard Entry Class Code: CCD 

Transaction Code: 22 

ACH debits are not permitted to this ABA routing number. All debits received will be 

automatically returned. 

Fedwire (Domestic Wire Transfer)

The Sender must use a bank that offers Fedwire funds transfer capability. Information regarding 

Fedwire, including listings of Fedwire funds transfer participants, may be found at 

http://www.frbservices.org 

Type/Subtype: 1000 

Receiver Short Name (Bank Name): TREAS NYC 

Location: 33 Libe7

ty Street, New York, NY 10045 

Receiver ABA Routing Number: 021030004 

Amount of funds to be transferred. 

Beneficiary Name: DFAS/Strategic Materials 

Beneficiary ID (Gateway Account#):800006355005 

Third Party Information - Vendor's Name, Commodity, and bill Number. 

NOTE:

Credit Gateway Agency Locator Code is 00006355 

International Wire info for payments in US Dollars: 

Bank Name & Address: Treas NYC, 33 Liberty Street New York, NY US 10045 

In place of the SWIFT CODE: //FW021030004 Remember the forward slashes 

The//FW021030004 is in place of SWIFT CODE - this instructs the Foreign Bank to have their USD

correspondent send the funds through FedWire to the Credit Gateway ABA of•021030004. 

Gateway Agency Locator Code is 00006355 

Beneficiary ID (Gateway Account#): 800006355005 

Beneficiary Name: DFAS/Strategic Materials 

Receiver Short Name: Treas NYC 

Account Name: Treas NYC, New York 

All international wire payments must include the following reference for payments to post to our 

account on block 57D line 1: ALC00006355DOD Columbus". This line only takes 35 characters.

Note on block 70, there are 4 lines each holding up to 35 characters. Lines 1 & 2 are 

guaranteed, Lines 3 and 4 are not. 

Block 71 must contain the word "OUR". 

All payments must also include Bill number(s). 

Please contact Strategic Materials at 571-767-5500 should you have any questions or concerns.
No. 10-11107.

#### Ronald Wayne Moore, Petitioner v. California.

565 U.S. 867, 132 S. Ct. 215,

181 L. Ed. 2d 117,

2011 U.S. LEXIS 7003.

October 3, 2011.

Petition for writ of certiorari to the Supreme Court of California denied.

Same case below, 51 Cal. 4th 386, 121 Cal. Rptr. 3d 280, 247 P.3d 515.
No. 11-5677.

#### Murray Randall Rogers, Petitioner v. Joseph N. Ingolia, et al.

565 U.S. 918, 132 S. Ct. 340,

181 L. Ed. 2d 213,

2011 U.S. LEXIS 7033.

October 3, 2011.

Petition for writ of certiorari to the United States Court of Appeals for the Fifth Circuit denied.

Same case below, 424 Fed. Appx. 283.
No. 11-5922.

#### Roger Arias, Petitioner v. Texas.

565 U.S. 967, 132 S. Ct. 461,

181 L. Ed. 2d 301,

2011 U.S. LEXIS 7542.

October 17, 2011.

Petition for writ of certiorari to the Court of Appeals of Texas, Fourth District, denied.
[Federal Register Volume 63, Number 138 (Monday, July 20, 1998)]
[Notices]
[Page 38821]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 98-19197]


-----------------------------------------------------------------------

DEPARTMENT OF ENERGY

Federal Energy Regulatory Commission
[Docket Nos. RP98-155-003 and TM98-4-4-001]


Granite State Gas Transmission, Inc.; Notice of Compliance Tariff 
Filing

July 14, 1998.
    Take notice that on July 8, 1998, Grante State Gas Transmission, 
Inc. (Granite State) tendered for filing as part of its FERC Gas 
Tariff, Third Revised Volume No. 1, Second Substitute First Revised 
Sheet No. 334, for effectiveness on July 1, 1998.
    According to Granite State, the revised tariff sheet is submitted 
in compliance with a provision in the Commission's Letter Order issued 
June 25, 1998 which, among other things, directed Granite State to 
insert certain clarifying language in its Power Cost Adjustment Tariff 
provisions.
    Granite State says that copies of its filing were served upon its 
firm and interruptible customers and the regulatory agencies of the 
states of Maine, Massachusetts and New Hampshire.
    Any person desiring to protest this filing should file a protest 
with the Federal Energy Regulatory Commission, 888 First Street, N.E., 
Washington, D.C. 20426, in accordance with Section 385.211 of the 
Commission's Rules and Regulations. All such protests must be filed as 
provided in Section 154.210 of the Commission's Regulations. Protests 
will be considered by the Commission in determining the appropriate 
action to be taken, but will not serve to make protestants parties to 
the proceedings. Copies of this filing are on file with the Commission 
and are available for public inspection in the Public Reference Roome.
Linwood A. Wason, Jr.,
Acting Secretary.
[FR Doc. 98-19197 Filed 7-17-98; 8:45 am]
BILLING CODE 6717-01-M
inuv_ex1013.htm


EXHIBIT 10.13


 


 





 




  





1











  






 





 




  





2











  






 





 




  





3











  






 






 




  





4











  








 






 




  





5











  








 






 




  





6











  








 






 




  





7











  








 






 




  





8











  








 






 




  





9











  








 






 




  





10
Exhibit 32.1

Certification
  by the Chief Executive Officer Pursuant to 18 U. S. C. Section 1350, as AdoptedPursuant to Section 906 of the Sarbanes-Oxley Act of 2002

Pursuant to 18 U. S. C.
  Section 1350, I, Arnold S. Lippa, hereby certify that, to the best of my knowledge,
  the Quarterly Report on Form 10-Q of DOV Pharmaceutical, Inc. for the quarter
  ended June 30, 2004 (the Report) fully complies with the requirements
  of Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934, and
  that the information contained in the Report fairly presents, in all material
  respects, the financial condition and results of operations of DOV Pharmaceutical,
  Inc.

A signed original of this
  written statement required by Section 906 has been provided to DOV and will
  be retained by DOV and furnished to the Securities and Exchange Commission or
  its staff upon request.

|/s/
      Arnold S. Lippa                                            
|---------------------------------------------------------------------
|                                                                     
|Arnold
      S. Lippa                                                
|Co-Chairman
      of the Board, Chief Executive Officer and President
|August
      9, 2004                                                 

This certification accompanies
  this Report on Form 10-Q pursuant to Section 906 of the Sarbanes-Oxley Act of
  2002 and shall not, except to the extent required by such Act, be deemed filed
  by the Company for purposes of Section 18 of the Securities Exchange Act of
  1934, as amended (the Exchange Act). Such certification will not
  be deemed to be incorporated by reference into any filing under the Securities
  Act of 1933, as amended, or the Exchange Act, except to the extent that the
  Company specifically incorporates it by reference.

---
**Exhibit 10.14**

AMENDMENT NO. 1 

FARMER BROS. CO. RETIREMENT PLAN 

The Plan named above gives the Employer the right to amend it at any time. According to that right, the Plan is amended effective June 30, 2011, asfollows: 

By striking the first sentence from the definition of **Accrual Service** in the DEFINITIONS 

SECTION of Article I and substituting the following: 

**Accrual Service**means an Employee’s Period of Service credited on or before June 30, 2011. 

By adding the following after the first paragraph of the definition of **Accrual****Service** in the 

DEFINITIONS SECTION of Article I: 

Accrual Service shall be frozen on and afterJune 30, 2011 for purposes of determining the Accrued Benefit on such date; however, for purposes of determining a Participant’s Early Retirement Age, Disability Retirement Date, or the deferred monthly retirement benefit for an InactiveParticipant beginning on his Early Retirement Date according to the VESTED BENEFITS SECTION of Article V, Accrual Service shall continue to be credited for Periods of Service on and after June 30, 2011. 

By striking the first paragraph from the definition of **Average Compensation**in the DEFINITIONS SECTION of Article I and substituting thefollowing: 

**Average Compensation**means, on any given date before June 30, 2011, the average of an Employee’sMonthly Compensation for those 60 consecutive calendar months of his Accrual Service (all such months, if less than 60) which give the highest average out of the 120 latest calendar months of his Accrual Service (all such months, if less than 120).

By adding the following after the last paragraph of the definition of Average Compensation in the DEFINITIONS SECTION of Article I:

On any given date on or after June 30, 2011, an Employee’s Average Compensation shall be his Average Compensationas of June 30, 2011. 

By adding the following as the final paragraph of the ACCRUED BENEFIT SECTION of Article IV: 

On and after June 30, 2011, the Accrued Benefit is frozen and no additional benefits shall accrue on and after such date.

This amendment is made an integral part of the aforesaid Plan and is controlling over the terms of said Plan with respect to the particularitems addressed expressly herein. All other provisions of the Plan remain unchanged and controlling. 

Unless otherwise stated on any page ofthis amendment, eligibility for benefits and the amount of any benefits payable to or on behalf of an individual who is an Inactive Participant on the effective date(s) stated above, shall be determined according to the provisions of the aforesaidPlan as in effect on the day before he became an Inactive Participant. 

 Amendment No. 1  1  (7-7104)

Signing this amendment, the Employer, as plan sponsor, has made the decision to adopt this plan amendment.The Employer is acting in reliance on its own discretion and on the legal and tax advice of its own advisors, and not that of any member of the Principal Financial Group or any representative of a member company of the Principal Financial Group.

Signed this 11 day of **MAY, 2011 

 
FARMERS BROS. COBy  /s/    Jeffrey Wahba CFO Title
 Amendment No. 1  2  (7-7104)
1 COURT OF APPEALS

EIGHTH DISTRICT OF TEXAS

EL PASO, TEXAS

ANTHONY G. BUZBEE, AND THE

BUZBEE LAW FIRM,

Appellant s

,

v.

ROBERTO CANALES, M.D. AND

ROBERTO CANALES, M.D. P.A



### .,

Appellee s

. §

§

§

§

§

§

§ No. 08

- 20

- 00138

- CV

Appeal from the

41st District Court

of El Paso County, Texas

(TC# 2020 DCV0691 )

O R D E R

Pending before the Court is Appellants' Unopposed Motion to Correct the Clerk's Record.

Appellants ask this Court to order that (1) a pagination error be corrected and (2) the Plaintiffs’

Amended Petition be excluded from the Clerk’s Record, or, alternatively, that a Supplemental

Clerk’s Record be filed which conta ins the Appellants’ Supplement to Request for Clerk’s Record

(a document filed with the trial court that appears to object to the filing of the amended petition

and asserts that an automatic stay is in place).

The Court GRANTS Appellants’ unopposed motion to supplement the Clerk’s Record, in

part, as follows:

• Appellants’ request for a correction of a pagination error in the Clerk’s Record is

GRANTED. Pursuant to Tex.R.App.P. 34.5(d), the District Clerk is ordered to sub mit a

Corrected Clerk’s Record that contains the missing pagination (from pages 82 to 113). The

Corrected Clerk’s Record is due before this Court on or before August 22, 20 20.

• Appellants’ request to exclude the Plaintiffs’ Amended Peti tion (CR 353

- 365) from the

Clerk’s Record/Correct Clerk’s Record is DENIED.2

• Appellants’ request to supplement the Clerk’s Record is GRANTED. The District Clerk is

ordered to file a Supplemental Clerk’s Record containing a copy of Appellants’

Supplement to Request for Clerk’s Record. The supplemental Clerk’s Record containing

the copy of the Appellants’ supplementation request is due in this Court on or before

August 22, 2020.

IT IS SO ORDERED this 12 th day of August

, 2020.

PER CURIAM

Before Alley, C.J., Rodriguez and Palafox, JJ.